Thioxanthine derivatives as myeloperoxidase inhibitors

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 473/36 (2006.01) A61K 31/52 (2006.01)

Patent

CA 2752132

There is disclosed the use of a compound of formula (Ia) or (Ib) wherein R1, R2, R3, R4, X and Y are as defined in the specification, and pharmaceutically acceptable salts thereof, in the manufacture of a medicament, for the treatment or prophylaxis of diseases or conditions in which inhibition of the enzyme myeloperoxidase (MPO) is beneficial. Certain novel compounds of formula (Ia) or (Ib) and pharmaceutically acceptable salts thereof are disclosed, together with processes for their preparation. The compounds of formulae (Ia) and (Ib) are MPO inhibitors and are thereby particularly useful in the treatment or prophylaxis of neuroinflammatory disorders. (see formula Ia) (see formula Ib)

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Thioxanthine derivatives as myeloperoxidase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Thioxanthine derivatives as myeloperoxidase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thioxanthine derivatives as myeloperoxidase inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1919532

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.